Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
15.18
-0.15 (-0.98%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $46.38 billion as of April 23, 2025. Its market cap has increased by 8.53% in one year.
Market Cap
46.38B
Enterprise Value
81.09B
1-Year Change
8.53%
Ranking
Category
Stock Price
$15.18
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $46.38B, a decrease of -34.87%. That is a compound annual growth rate of -2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 48.60B | 15.37% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |